FDA Advisory Committee Votes to Recommend Additional Data fo

/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) held a public Oncology Drug Advisory Committee (ODAC) for sintilimab, which is under review for the...

Related Keywords

China , Taiwan , United States , Hong Kong , Suzhou , Jiangsu , Macau , American , Innovent Biologics , Adimab Incyte , Yongjun Liu , Eli Lilly , Jacob Van Naarden , Oncology Drug Advisory Committee , Drug Administration , Md Anderson Cancer Center , National Reimbursement Drug List , International Agency For Research On Cancer , American Cancer Society , Incyte Corporation , Radiographic Review Committee , Independent Radiographic Review Committee , Main Board , Stock Exchange , Hong Kong Limited , Cancer Center , Mainland China , International Agency , Cancer Fact , Accessed January , American Cancer , Key Statistics , Non Small Cell Lung Cancer , Pharmaceuticals , Medical Pharmaceuticals , Health Care Amp Hospitals , Fda Approval ,